Comprehensive meta analysis v2
![comprehensive meta analysis v2 comprehensive meta analysis v2](https://www.frontiersin.org/files/Articles/422935/fonc-08-00601-HTML-r1/image_m/fonc-08-00601-g001.jpg)
3, 5, 6Īccording to the official statistics, at the end of 2011, 780 000 people were living with HIV in China of which female patients accounted for 28.6%. 4 These guidelines support the implementation of the Global Plan and Asia Pacific Frameworks towards the elimination of new HIV infections that may occur among children. In some countries, for women who are not eligible for ART according to national guidelines, stopping ART after cessation of mother-to-child transmission (MTCT) risk could be considered. 1– WHO guidelines recommend that all HIV-positive pregnant and breastfeeding women start antiretroviral therapy (ART) as early as during 14 weeks of pregnancy and continue lifelong treatment if resources are available particularly in generalised epidemics. However, while including transmissions among HIV-positive pregnant women who were lost along the cascade, the average transmission rate during 2003–2011 was 17.4% (15.8% to 19.0%).Įffective prevention of mother-to-child transmission (PMTCT) of HIV can reduce the vertical transmission risk from 15%–45% to below 5% in breastfeeding populations and below 2% in non-breastfeeding populations. During 2003–2011, among 25 312 (23 995–26 644) infants born to HIV-positive mothers who received ARV prophylaxis, 975 (564–1395) were diagnosed with HIV, corresponding to an average transmission rate of 3.9% (3.2% to 4.6%). HIV vertical transmission rate substantially decreased from 31.8% (25.7% to 38.6%) prior to the programme to 2.3% (1.4% to 3.8%) in 2011.
![comprehensive meta analysis v2 comprehensive meta analysis v2](https://www.meta-analysis.com/Images/content/screenshots/index.gif)
HIV prevalence among pregnant women in China who accessed antenatal care (ANC) remained below 0.1% during the past decade. Results This study included 113 publications. Huan Zeng, School of Public Health and Management, Chongqing Medical University, Chongqing, China, 400016 11 School of Medicine, Research Center for Public Health, Tsinghua University, Beijing, China.10 Department of HIV&STI, WHO Regional Office for the Western Pacific, Manila, The Philippines.9 Women's Health Department, National Center for Women's and Children's Health, China CDC, Beijing, China.
![comprehensive meta analysis v2 comprehensive meta analysis v2](https://www.meta-analysis.com/Images/img-productcase.jpg)